{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["apoptosis", "cancer", "molecular mechanism", "multidrug resistance", "secondary metaabolites"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34093189", "DateRevised": {"Year": "2021", "Month": "06", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "05", "Day": "21"}], "Language": ["eng"], "ELocationID": ["658513", "10.3389/fphar.2021.658513"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites.", "Pagination": {"StartPage": "658513", "MedlinePgn": "658513"}, "Abstract": {"AbstractText": ["Plant secondary metabolites (SMs) common natural occurrences and the significantly lower toxicities of many SM have led to the approaching development and use of these compounds as effective pharmaceutical agents; especially in cancer therapy. A combination of two or three of plant secondary metabolites together or of one SM with specific anticancer drugs, may synergistically decrease the doses needed, widen the chemotherapeutic window, mediate more effective cell growth inhibition, and avoid the side effects of high drug concentrations. In mixtures they can exert additive or even synergistic activities. Many SM can effectively increase the sensitivity of cancer cells to chemotherapy. In phytotherapy, secondary metabolites (SM) of medicinal plants can interact with single or multiple targets. The multi-molecular mechanisms of plant secondary metabolites to overcome multidrug resistance (MDR) are highlighted in this review. These mechanisms include interaction with membrane proteins such as P-glycoprotein (P-gp/MDR1); an ATP-binding cassette (ABC) transporter, nucleic acids (DNA, RNA), and induction of apoptosis. P-gp plays an important role in the development of MDR in cancer cells and is involved in potential chemotherapy failure. Therefore, the ingestion of dietary supplements, food or beverages containing secondary metabolites e.g., polyphenols or terpenoids may alter the bioavailability, therapeutic efficacy and safety of the drugs that are P-gp substrates."], "CopyrightInformation": "Copyright \u00a9 2021 El-Readi, Al-Abd, Althubiti, Almaimani, Al-Amoodi, Ashour, Wink and Eid."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt."}], "LastName": "El-Readi", "ForeName": "Mahmoud Zaki", "Initials": "MZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy & Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates."}, {"Identifier": [], "Affiliation": "Pharmacology Department, Medical Division, National Research Centre, Cairo, Egypt."}], "LastName": "Al-Abd", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Althubiti", "ForeName": "Mohammad A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Almaimani", "ForeName": "Riyad A", "Initials": "RA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Al-Amoodi", "ForeName": "Hiba Saeed", "Initials": "HS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt."}], "LastName": "Ashour", "ForeName": "Mohamed Lotfy", "Initials": "ML"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany."}], "LastName": "Wink", "ForeName": "Michael", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Eid", "ForeName": "Safaa Yehia", "Initials": "SY"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abdalla A. N., Abdallah M. E., Aslam A., Bader A., Vassallo A., Tommasi N., et al. (2020). Synergistic Anti Leukemia Effect of a Novel Hsp90 and a Pan Cyclin Dependent Kinase Inhibitors. Molecules 25, 2220. 10.3390/molecules25092220", "ArticleIdList": ["10.3390/molecules25092220", "PMC7248782", "32397330"]}, {"Citation": "Abdallah M. E., El-Readi M. Z., Althubiti M. A., Almaimani R. A., Ismail A. M., Idris S., et al. (2020). Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. Molecules 25, 3355. 10.3390/molecules25153355", "ArticleIdList": ["10.3390/molecules25153355", "PMC7436112", "32722075"]}, {"Citation": "Akhtar N., Ahad A., Khar R. K., Jaggi M., Aqil M., Iqbal Z., et al. (2011). The Emerging Role of P-Glycoprotein Inhibitors in Drug Delivery: a Patent Review. Expert Opin. Ther. Patents 21, 561\u2013576. 10.1517/13543776.2011.561784", "ArticleIdList": ["10.1517/13543776.2011.561784", "21413912"]}, {"Citation": "Alberti P., Lacroix L., Guittat L., Helene C., Mergny J.-L. (2003). Nucleic Acids as Targets for Antitelomerase Agents. Mini. Rev. Med. Chem. 3, 23\u201336. 10.2174/1389557033405485", "ArticleIdList": ["10.2174/1389557033405485", "12570852"]}, {"Citation": "Alberts B. (2008). Molecular Biology of the Cell. 5th edition. New York: Extended version, Garland Science."}, {"Citation": "Alexander S. P. H., Armstrong J. F., Kelly E., Mathie A., Peters J. A., Veale E. L., et al. (2019a). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets. Br. J. Pharmacol. 176 (Suppl. 1), S1\u2013S20. 10.1111/bph.14747", "ArticleIdList": ["10.1111/bph.14747", "PMC6844537", "31710719"]}, {"Citation": "Alexander S. P. H., Cidlowski J. A., Kelly E., Mathie A., Peters J. A., Veale E. L., et al. (2019b). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear Hormone Receptors. Br. J. Pharmacol. 176 (Suppl. 1), S397\u2013S493. 10.1111/bph.14750", "ArticleIdList": ["10.1111/bph.14750", "PMC6844575", "31710718"]}, {"Citation": "Alexander S. P. H., Christopoulos A., Davenport A. P., Kelly E., Mathie A., Peters J. A., et al. (2019c). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors. Br. J. Pharmacol. 176 (Suppl. 1), S21\u2013S141. 10.1111/bph.14748", "ArticleIdList": ["10.1111/bph.14748", "PMC6844580", "31710717"]}, {"Citation": "Alexander S. P. H., Kelly E., Mathie A., Peters J. A., Veale E. L., Armstrong J. F., et al. (2019d). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters. Br. J. Pharmacol. 176 (Suppl. 1), S397\u2013S493. 10.1111/bph.14753", "ArticleIdList": ["10.1111/bph.14753", "PMC6844579", "31710713"]}, {"Citation": "Alexander S. P. H., Fabbro D., Kelly E., Mathie A., Peters J. A., Veale E. L., et al. (2019e). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic Receptors. Br. J. Pharmacol. 176 (Suppl. 1), S247\u2013S296. 10.1111/bph.14751", "ArticleIdList": ["10.1111/bph.14751", "PMC6844576", "31710716"]}, {"Citation": "Alexander S. P. H., Kelly E., Mathie A., Peters J. A., Veale E. L., Striessnig J., et al. (2019f). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Br. J. Pharmacol. 176 (Suppl. 1), S142\u2013S228. 10.1111/bph.14749", "ArticleIdList": ["10.1111/bph.14749", "PMC6844578", "31710715"]}, {"Citation": "Alexander S. P. H., Fabbro D., Kelly E., Mathie A., Peters J. A., Veale E. L., et al. (2019g). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes. Br. J. Pharmacol. 176 (Suppl. 1), S297\u2013S396. 10.1111/bph.14752", "ArticleIdList": ["10.1111/bph.14752", "PMC6844577", "31710714"]}, {"Citation": "Alison M. (2002). The Cancer Handbook. London: Nature."}, {"Citation": "Amin M. L. (2013). P-glycoprotein Inhibition for Optimal Drug Delivery. Drug Target. Insights 7, 27\u201334. 10.4137/dti.s12519", "ArticleIdList": ["10.4137/dti.s12519", "PMC3762612", "24023511"]}, {"Citation": "Bailly C. (2000). Topoisomerase I Poisons and Suppressors as Anticancer Drugs. Curr. Med. Chem. 7, 39\u201358. 10.2174/0929867003375489", "ArticleIdList": ["10.2174/0929867003375489", "10637356"]}, {"Citation": "Bathaie S. Z., Bolhasani A., Hoshyar R., Ranjbar B., Sabouni F., Moosavi-Movahedi A. A., (2007), Interaction of Saffron Carotenoids as Anticancer Compounds with ctDNA, Oligo (dG.dC)15, and Oligo (dA.dT)15, DNA Cell Biol. 26, 533\u2013540. 10.1089/dna.2007.0598", "ArticleIdList": ["10.1089/dna.2007.0598", "17688404"]}, {"Citation": "Bellamy C. O. C., Malcolmson R. D. G., Harrison D. J., Wyllie A. H. (1995). Cell Death in Health and Disease: the Biology and Regulation of Apoptosis. Semin. Cancer Biol. 6, 3\u201316. 10.1006/scbi.1995.0002", "ArticleIdList": ["10.1006/scbi.1995.0002", "7548839"]}, {"Citation": "Berenbaum M. C. (1989). What Is Synergy? Pharmacol. Rev. 41, 93\u2013141.", "ArticleIdList": ["2692037"]}, {"Citation": "Borst P., Schinkel A. H. (1997). Genetic Dissection of the Function of Mammalian P-Glycoproteins. Trends Genet. 13, 217\u2013222. 10.1016/s0168-9525(97)01112-8", "ArticleIdList": ["10.1016/s0168-9525(97)01112-8", "9196326"]}, {"Citation": "Cao M.-R., Li Q., Liu Z.-L., Liu H.-H., Wang W., Liao X.-L., et al. (2011). Harmine Induces Apoptosis in HepG2 Cells via Mitochondrial Signaling Pathway. Hepatobiliary Pancreat. Dis. Int. 10, 599\u2013604. 10.1016/s1499-3872(11)60102-1", "ArticleIdList": ["10.1016/s1499-3872(11)60102-1", "22146623"]}, {"Citation": "Cascorbi I. (2011). P-glycoprotein: Tissue Distribution, Substrates, and Functional Consequences of Genetic Variations. Handbook Exp. Pharmacol. 201, 261\u2013283. 10.1007/978-3-642-14541-4_6", "ArticleIdList": ["10.1007/978-3-642-14541-4_6", "21103972"]}, {"Citation": "Chan W.-H. (2011). Embryonic Toxicity of Sanguinarine through Apoptotic Processes in Mouse Blastocysts. Toxicol. Lett. 205, 285\u2013292. 10.1016/j.toxlet.2011.06.018", "ArticleIdList": ["10.1016/j.toxlet.2011.06.018", "21722720"]}, {"Citation": "Cho W. C. (2007). Contribution of Oncoproteomics to Cancer Biomarker Discovery. Mol. Cancer 6, 25. 10.1186/1476-4598-6-25", "ArticleIdList": ["10.1186/1476-4598-6-25", "PMC1852117", "17407558"]}, {"Citation": "Chou T.-C. (2006). Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies. Pharmacol. Rev. 58, 621\u2013681. 10.1124/pr.58.3.10", "ArticleIdList": ["10.1124/pr.58.3.10", "16968952"]}, {"Citation": "Choudhuri S., Klaassen C. D. (2006). Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters. Int. J. Toxicol. 25, 231\u2013259. 10.1080/10915810600746023", "ArticleIdList": ["10.1080/10915810600746023", "16815813"]}, {"Citation": "Cianchetta G., Singleton R. W., Zhang M., Wildgoose M., Giesing D., Fravolini A., et al. (2005). A Pharmacophore Hypothesis for P-Glycoprotein Substrate Recognition Using GRIND-Based 3D-QSAR. J. Med. Chem. 48, 2927\u20132935. 10.1021/jm0491851", "ArticleIdList": ["10.1021/jm0491851", "15828831"]}, {"Citation": "Coley H. M. (2010). Overcoming Multidrug Resistance in Cancer: Clinical Studies of P-Glycoprotein Inhibitors. Methods Mol. Biol. 596, 341\u2013358. 10.1007/978-1-60761-416-6_15", "ArticleIdList": ["10.1007/978-1-60761-416-6_15", "19949931"]}, {"Citation": "Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R., et al. (1989). Multidrug-resistance Gene (P-Glycoprotein) Is Expressed by Endothelial Cells at Blood-Brain Barrier Sites. Proc. Natl. Acad. Sci. 86, 695\u2013698. 10.1073/pnas.86.2.695", "ArticleIdList": ["10.1073/pnas.86.2.695", "PMC286540", "2563168"]}, {"Citation": "Cragg G. M., Boyd M. (1996). \u201cDrug Discovery and Development at the National Cancer Institute,\u201d in Medicinal Resources of the Tropical Forest : Biodiversity and its Importance to Human Health. Editors Balick M. J., Elisabetsky E., Laird S. A. (New York: Columbia University Press; ), 101."}, {"Citation": "DuBuske L. M. (2005). The Role of P-Glycoprotein and Organic Anion-Transporting Polypeptides in Drug Interactions. Drug Saf. 28, 789\u2013801. 10.2165/00002018-200528090-00004", "ArticleIdList": ["10.2165/00002018-200528090-00004", "16119972"]}, {"Citation": "Ecker G., Huber M., Schmid D., Chiba P. (1999). The Importance of a Nitrogen Atom in Modulators of Multidrug Resistance. Mol. Pharmacol. 56, 791\u2013796.", "ArticleIdList": ["10496963"]}, {"Citation": "Eckford P. D. W., Sharom F. J. (2009). ABC Efflux Pump-Based Resistance to Chemotherapy Drugs. Chem. Rev. 109, 2989\u20133011. 10.1021/cr9000226", "ArticleIdList": ["10.1021/cr9000226", "19583429"]}, {"Citation": "Efferth T., Greten H. J. (2012). The European Directive on Traditional Herbal Medicinal Products: Friend or Foe for Plant-Based Therapies? J. Chin. Integr. Med. 10, 357\u2013361. 10.3736/jcim20120401", "ArticleIdList": ["10.3736/jcim20120401", "22500706"]}, {"Citation": "Efferth T., Koch E. (2011). Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy. Curr. Drug Targets 12, 122\u2013132. 10.2174/138945011793591626", "ArticleIdList": ["10.2174/138945011793591626", "20735354"]}, {"Citation": "Efferth T. (2001). The Human ATP-Binding Cassette Transporter Genes From the Bench to the Bedside. Curr. Mol. Med. 1, 45\u201365. 10.2174/1566524013364194", "ArticleIdList": ["10.2174/1566524013364194", "11899242"]}, {"Citation": "Efferth T. (2010). Cancer Therapy with Natural Products and Medicinal Plants. Planta Med. 76, 1035\u20131036. 10.1055/s-0030-1250062", "ArticleIdList": ["10.1055/s-0030-1250062", "20665401"]}, {"Citation": "Eichhorn T., Efferth T. (2012). P-glycoprotein and its Inhibition in Tumors by Phytochemicals Derived from Chinese Herbs. J. Ethnopharmacology 141, 557\u2013570. 10.1016/j.jep.2011.08.053", "ArticleIdList": ["10.1016/j.jep.2011.08.053", "21963565"]}, {"Citation": "Eid S. Y., El-Readi M. Z., Wink M. (2012a). Carotenoids Reverse Multidrug Resistance in Cancer Cells by Interfering with ABC-Transporters. Phytomedicine 19, 977\u2013987. 10.1016/j.phymed.2012.05.010", "ArticleIdList": ["10.1016/j.phymed.2012.05.010", "22770743"]}, {"Citation": "Eid S. Y., El-Readi M. Z., Wink M. (2012b). Synergism of Three-Drug Combinations of Sanguinarine and Other Plant Secondary Metabolites with Digitonin and Doxorubicin in Multi-Drug Resistant Cancer Cells. Phytomedicine 19, 1288\u20131297. 10.1016/j.phymed.2012.08.010", "ArticleIdList": ["10.1016/j.phymed.2012.08.010", "23146422"]}, {"Citation": "Eid S. Y., El-Readi M. Z., Eldin E. E. M. N., Fatani S. H., Wink M. (2013). Influence of Combinations of Digitonin with Selected Phenolics, Terpenoids, and Alkaloids on the Expression and Activity of P-Glycoprotein in Leukaemia and Colon Cancer Cells. Phytomedicine 21, 47\u201361. 10.1016/j.phymed.2013.07.019", "ArticleIdList": ["10.1016/j.phymed.2013.07.019", "23999162"]}, {"Citation": "Eid S. Y., El-Readi M. Z., Ashour M. L., Wink M. (2015). Fallopia Japonica, a Natural Modulator, Can Overcome Multidrug Resistance in Cancer Cells. Evidence-Based Complementary and Alternative Medicine. eCAM 2015, 868424. 10.1155/2015/868424", "ArticleIdList": ["10.1155/2015/868424", "PMC4545274", "26346937"]}, {"Citation": "Eid S. Y., Althubiti M. A., Abdallah M. E., Wink M., El-Readi M. Z. (2020). The Carotenoid Fucoxanthin Can Sensitize Multidrug Resistant Cancer Cells to Doxorubicin via Induction of Apoptosis, Inhibition of Multidrug Resistance Proteins and Metabolic Enzymes. Phytomedicine 77, 153280. 10.1016/j.phymed.2020.153280", "ArticleIdList": ["10.1016/j.phymed.2020.153280", "32712543"]}, {"Citation": "El-Readi M. Z., Hamdan D., Farrag N., El-Shazly A., Wink M. (2010). Inhibition of P-Glycoprotein Activity by Limonin and Other Secondary Metabolites from Citrus Species in Human Colon and Leukaemia Cell Lines. Eur. J. Pharmacol. 626, 139\u2013145. 10.1016/j.ejphar.2009.09.040", "ArticleIdList": ["10.1016/j.ejphar.2009.09.040", "19782062"]}, {"Citation": "El-Readi M. Z., Eid S., Ashour M. L., Tahrani A., Wink M. (2013). Modulation of Multidrug Resistance in Cancer Cells by Chelidonine and Chelidonium Majus Alkaloids. Phytomedicine 20, 282\u2013294. 10.1016/j.phymed.2012.11.005", "ArticleIdList": ["10.1016/j.phymed.2012.11.005", "23238299"]}, {"Citation": "El-Readi M. Z., Eid S., Abdelghany A. A., Al-Amoudi H. S., Efferth T., Wink M. (2019). Resveratrol Mediated Cancer Cell Apoptosis, and Modulation of Multidrug Resistance Proteins and Metabolic Enzymes. Phytomedicine 55, 269\u2013281. 10.1016/j.phymed.2018.06.046", "ArticleIdList": ["10.1016/j.phymed.2018.06.046", "30668439"]}, {"Citation": "Eytan G. D., Kuchel P. W. (1999). Mechanism of Action of P-Glycoprotein in Relation to Passive Membrane Permeation. Int. Rev. Cytol. - a Surv. Cell Biol. 190, 175\u2013250. 10.1016/s0074-7696(08)62148-8", "ArticleIdList": ["10.1016/s0074-7696(08)62148-8", "10331240"]}, {"Citation": "Eytan G. D., Regev R., Oren G., Assaraf Y. G. (1996). The Role of Passive Transbilayer Drug Movement in Multidrug Resistance and its Modulation. J. Biol. Chem. 271, 12897\u201312902. 10.1074/jbc.271.22.12897", "ArticleIdList": ["10.1074/jbc.271.22.12897", "8662680"]}, {"Citation": "Fan D., Beltran P. J., O\u2019Brien C. A. (1994). Reversal of Multidrug Resistance (Boca Raton, FL: CRC Press; )."}, {"Citation": "Ferlay J., Shin H.-R., Bray F., Forman D., Mathers C., Parkin D. M. (2010). Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893\u20132917. 10.1002/ijc.25516", "ArticleIdList": ["10.1002/ijc.25516", "21351269"]}, {"Citation": "Fricker G., Miller D. S. (2002). Relevance of Multidrug Resistance Proteins for Intestinal Drug Absorption In Vitro and In Vivo. Pharmacol. Toxicol. 90, 5\u201313. 10.1034/j.1600-0773.2002.900103.x", "ArticleIdList": ["10.1034/j.1600-0773.2002.900103.x", "12005113"]}, {"Citation": "Fricker G., Miller D. S. (2004). Modulation of Drug Transporters at the Blood-Brain Barrier. Pharmacology 70, 169\u2013176. 10.1159/000075545", "ArticleIdList": ["10.1159/000075545", "15001817"]}, {"Citation": "Fricker G., Drewe J., Miller D. S. (1998). Excretion of a Fluorescent Rapamycin-Derivative in Proximal Kidney Tubules Is Mediated by P-Glycoprotein. Int. J. Clin. Pharmacol. Ther. 36, 67\u201369.", "ArticleIdList": ["9520145"]}, {"Citation": "Fricker G. (2008). Drug Interactions with Natural Products at the Blood Brain Barrier. Curr. Drug. Metab. 9, 1019\u20131026. 10.2174/138920008786927758", "ArticleIdList": ["10.2174/138920008786927758", "19075618"]}, {"Citation": "Fu D., Arias I. M. (2012). Intracellular Trafficking of P-Glycoprotein. Int. J. Biochem. Cell Biol. 44, 461\u2013464. 10.1016/j.biocel.2011.12.009", "ArticleIdList": ["10.1016/j.biocel.2011.12.009", "PMC3288648", "22212176"]}, {"Citation": "Ganguly A., Das B., Roy A., Sen N., Dasgupta S. B., Mukhopadhayay S., et al. (2007). Betulinic Acid, a Catalytic Inhibitor of Topoisomerase I, Inhibits Reactive Oxygen Species Mediated Apoptotic Topoisomerase I DNA Cleavable Complex Formation in Prostate Cancer Cells but Does Not Affect the Process of Cell Death. Cancer Res. 67, 11848\u201311858. 10.1158/0008-5472.can-07-1615", "ArticleIdList": ["10.1158/0008-5472.can-07-1615", "18089815"]}, {"Citation": "Garbett N., Graves D. (2004). Extending Natures Leads: The Anticancer Agent Ellipticine. Cmcaca 4, 149\u2013172. 10.2174/1568011043482070", "ArticleIdList": ["10.2174/1568011043482070", "15032720"]}, {"Citation": "Gatto B., Sanders M. M., Yu C., Wu H. Y., Makhey D., LaVoie E. J., et al. (1996). Identification of Topoisomerase I as the Cytotoxic Target of the Protoberberine Alkaloid Coralyne. Cancer Res. 56, 2795\u20132800.", "ArticleIdList": ["8665516"]}, {"Citation": "Gierke S., Kumar P., Wittmann T. (2010). Analysis of Microtubule Polymerization Dynamics in Live Cells. Methods Cell Biol 97, 15\u201333. 10.1016/s0091-679x(10)97002-7", "ArticleIdList": ["10.1016/s0091-679x(10)97002-7", "PMC3495240", "20719263"]}, {"Citation": "Gimenez-Bonafe P., Tortosa A., Perez-Tomas R. (2009). Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells. Curr. Cancer Drug Targets 9, 320\u2013340. 10.2174/156800909788166600", "ArticleIdList": ["10.2174/156800909788166600", "19442052"]}, {"Citation": "Goss P. E., Baker M. A., Carver J. P., Dennis J. W. (1995). Inhibitors of Carbohydrate Processing: A New Class of Anticancer Agents. Clin. Cancer Res. 1, 935\u2013944.", "ArticleIdList": ["9816064"]}, {"Citation": "Gottesman M. M., Pastan I. (1993). Biochemistry of Multidrug Resistance Mediated by the Multidrug Transporter. Annu. Rev. Biochem. 62, 385\u2013427. 10.1146/annurev.bi.62.070193.002125", "ArticleIdList": ["10.1146/annurev.bi.62.070193.002125", "8102521"]}, {"Citation": "Gottesman M. M., Fojo T., Bates S. E. (2002). Multidrug Resistance in Cancer: Role of ATP-dependent Transporters. Nat. Rev. Cancer 2, 48\u201358. 10.1038/nrc706", "ArticleIdList": ["10.1038/nrc706", "11902585"]}, {"Citation": "Graham J. G., Quinn M. L., Fabricant D. S., Farnsworth N. R. (2000). Plants Used against Cancer - an Extension of the Work of Jonathan Hartwell. J. Ethnopharmacology 73, 347\u2013377. 10.1016/s0378-8741(00)00341-x", "ArticleIdList": ["10.1016/s0378-8741(00)00341-x", "11090989"]}, {"Citation": "Greider C. W., Blackburn E. H. (1985). Identification of a Specific Telomere Terminal Transferase Activity in Tetrahymena Extracts. Cell 43, 405\u2013413. 10.1016/0092-8674(85)90170-9", "ArticleIdList": ["10.1016/0092-8674(85)90170-9", "3907856"]}, {"Citation": "Greiner B., Eichelbaum M., Fritz P., Kreichgauer H.-P., Von Richter O., Zundler J., et al. (1999). The Role of Intestinal P-Glycoprotein in the Interaction of Digoxin and Rifampin. J. Clin. Invest. 104, 147\u2013153. 10.1172/jci6663", "ArticleIdList": ["10.1172/jci6663", "PMC408477", "10411543"]}, {"Citation": "Guittat L., Alberti P., Rosu F., Van Miert S., Thetiot E., Pieters L., et al. (2003). Interactions of Cryptolepine and Neocryptolepine with Unusual DNA Structures. Biochimie 85, 535\u2013547. 10.1016/s0300-9084(03)00035-x", "ArticleIdList": ["10.1016/s0300-9084(03)00035-x", "12763313"]}, {"Citation": "Gutmann H., Fricker G., T\u00f6r\u00f6k M., Michael S., Beglinger C., Drewe J. (1999). Evidence for Different ABC-Transporters in Caco-2 Cells Modulating Drug Uptake. Pharm. Res. 16, 402\u2013407. 10.1023/a:1018825819249", "ArticleIdList": ["10.1023/a:1018825819249", "10213371"]}, {"Citation": "Hamsa T., Kuttan G. (2011). Harmine Activates Intrinsic and Extrinsic Pathways of Apoptosis in B16F-10 Melanoma. Chin. Med. 6, 11. 10.1186/1749-8546-6-11", "ArticleIdList": ["10.1186/1749-8546-6-11", "PMC3076298", "21429205"]}, {"Citation": "Hartwell J. L. (1982). Plants Used against Cancer : A Survey. Lawrence, Mass: Quarterman Publications."}, {"Citation": "Hathcock K. S., Hodes R. J., Weng N. P. (2004). Analysis of Telomere Length and Telomerase Activity. Curr. Protoc. Immunol. Chapter 10, Unit 10.30. 10.1002/0471142735.im1030s62", "ArticleIdList": ["10.1002/0471142735.im1030s62", "18432920"]}, {"Citation": "Higgins C. F., Gottesman M. M. (1992). Is the Multidrug Transporter a Flippase? Trends Biochem. Sci. 17, 18\u201321. 10.1016/0968-0004(92)90419-a", "ArticleIdList": ["10.1016/0968-0004(92)90419-a", "1374941"]}, {"Citation": "Higgins C. F. (1992). ABC Transporters: From Microorganisms to Man. Annu. Rev. Cell. Biol. 8, 67\u2013113. 10.1146/annurev.cb.08.110192.000435", "ArticleIdList": ["10.1146/annurev.cb.08.110192.000435", "1282354"]}, {"Citation": "Hill G. M., Moriarity D. M., Setzer W. N. (2011). Attenuation of Cytotoxic Natural Product DNA Intercalating Agents by Caffeine. Sci. Pharm. 79, 729\u2013747. 10.3797/scipharm.1107-19", "ArticleIdList": ["10.3797/scipharm.1107-19", "PMC3221498", "22145102"]}, {"Citation": "Homolya L., Holl\u00f3 Z., Germann U. A., Pastan I., Gottesman M. M., Sarkadi B. (1993). Fluorescent Cellular Indicators Are Extruded by the Multidrug Resistance Protein. J. Biol. Chem. 268, 21493\u201321496. 10.1016/s0021-9258(20)80566-3", "ArticleIdList": ["10.1016/s0021-9258(20)80566-3", "8104940"]}, {"Citation": "Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D. (2011). Global Cancer Statistics. CA: a Cancer J. clinicians 61, 69\u201390. 10.3322/caac.20107", "ArticleIdList": ["10.3322/caac.20107", "21296855"]}, {"Citation": "Ji X., Chen J., Sun H., Zhou H., Xiang J., Peng A., et al. (2011). The Interaction of Telomere DNA G-Quadruplex with Threebis-Benzyltetrahydroisoquinoline Alkaloids. Nucleic acid Ther. 21, 415\u2013422. 10.1089/nat.2011.0311", "ArticleIdList": ["10.1089/nat.2011.0311", "22017543"]}, {"Citation": "Kerr J. F. R., Wyllie A. H., Currie A. R. (1972). Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics. Br. J. Cancer 26, 239\u2013257. 10.1038/bjc.1972.33", "ArticleIdList": ["10.1038/bjc.1972.33", "PMC2008650", "4561027"]}, {"Citation": "Khare V. M., Saxena V. K., Tomar A., Singh K. P., Singh K. B., Tiwari A. K. (2018). MHC-B Haplotypes Impact Susceptibility and Resistance to RSV-A Infection. Front. Biosci. 10, 506\u2013519. 10.2741/e837", "ArticleIdList": ["10.2741/e837", "29772523"]}, {"Citation": "Khare V. M., Saxena V. K., Tomar A., Nyinawabera A., Singh K. B., Ashby C. R., et al. (2019). Cytokine Gene Expression Following RSV-A Infection. Front. Biosci. 24, 463\u2013481. 10.2741/4729", "ArticleIdList": ["10.2741/4729", "30468667"]}, {"Citation": "K\u00fchnle M., Egger M., M\u00fcller C., Mahringer A., Bernhardt G., Fricker G., et al. (2009). Potent and Selective Inhibitors of Breast Cancer Resistance Protein (ABCG2) Derived from the P-Glycoprotein (ABCB1) Modulator Tariquidar. J. Med. Chem. 52, 1190\u20131197. 10.1021/jm8013822", "ArticleIdList": ["10.1021/jm8013822", "19170519"]}, {"Citation": "LaCasse E. C., Mahoney D. J., Cheung H. H., Plenchette S., Baird S., Korneluk R. G. (2008). IAP-targeted Therapies for Cancer. Oncogene 27, 6252\u20136275. 10.1038/onc.2008.302", "ArticleIdList": ["10.1038/onc.2008.302", "18931692"]}, {"Citation": "Lee J. S., Jung W.-K., Jeong M. H., Yoon T. R., Kim H. K. (2012). Sanguinarine Induces Apoptosis of HT-29 Human Colon Cancer Cells via the Regulation of Bax/Bcl-2 Ratio and Caspase-9-dependent Pathway. Int. J. Toxicol. 31, 70\u201377. 10.1177/1091581811423845", "ArticleIdList": ["10.1177/1091581811423845", "22215411"]}, {"Citation": "Levy M. Z., Allsopp R. C., Futcher A. B., Greider C. W., Harley C. B. (1992). Telomere End-Replication Problem and Cell Aging. J. Mol. Biol. 225, 951\u2013960. 10.1016/0022-2836(92)90096-3", "ArticleIdList": ["10.1016/0022-2836(92)90096-3", "1613801"]}, {"Citation": "Li X., Li J.-P., Yuan H.-Y., Gao X., Qu X.-J., Xu W.-F., et al. (2007). Recent Advances in P-Gp-Mediated MDR Reversal Mechanisms. Methods Find Exp. Clin. Pharmacol. 29, 607\u2013617. 10.1358/mf.2007.29.9.1139054", "ArticleIdList": ["10.1358/mf.2007.29.9.1139054", "18193112"]}, {"Citation": "Li G., Zhang C., Liang W., Zhang Y., Shen Y., Tian X. (2021). Berberine Regulates the Notch1/PTEN/PI3K/AKT/mTOR Pathway and Acts Synergistically with 17-AAG and SAHA in SW480 Colon Cancer Cells. Pharm. Biol. 59, 21\u201330. 10.1080/13880209.2020.1865407", "ArticleIdList": ["10.1080/13880209.2020.1865407", "PMC7808376", "33417512"]}, {"Citation": "Li-Blatter X., Beck A., Seelig A. (2012). P-glycoprotein-ATPase Modulation: the Molecular Mechanisms. Biophysical J. 102, 1383\u20131393. 10.1016/j.bpj.2012.02.018", "ArticleIdList": ["10.1016/j.bpj.2012.02.018", "PMC3309411", "22455921"]}, {"Citation": "Lin J. H., Yamazaki M. (2003). Clinical Relevance of P-Glycoprotein in Drug Therapy. Drug Metab. Rev. 35, 417\u2013454. 10.1081/dmr-120026871", "ArticleIdList": ["10.1081/dmr-120026871", "14705869"]}, {"Citation": "Lin J. P., Lu H. F., Lee J. H., Lin J. G., Hsia T. C., Wu L. T., et al. (2005). (-)-Menthol Inhibits DNA Topoisomerases I, II Alpha and Beta and Promotes NF-kappaB Expression in Human Gastric Cancer SNU-5 Cells. Anticancer Res. 25, 2069\u20132074.", "ArticleIdList": ["16158947"]}, {"Citation": "Liu L., Berletch J. B., Green J. G., Pate M. S., Andrews L. G., Tollefsbol T. O. (2004). Telomerase Inhibition by Retinoids Precedes Cytodifferentiation of Leukemia Cells and May Contribute to Terminal Differentiation. Mol. Cancer Ther. 3, 1003\u20131009.", "ArticleIdList": ["15299083"]}, {"Citation": "Lobert S., Vulevic B., Correia J. J. (1996). Interaction of Vinca Alkaloids with Tubulin: A Comparison of Vinblastine, Vincristine, and Vinorelbine. Biochemistry 35, 6806\u20136814. 10.1021/bi953037i", "ArticleIdList": ["10.1021/bi953037i", "8639632"]}, {"Citation": "Loo T. W., Clarke D. M. (1999). The Transmembrane Domains of the Human Multidrug Resistance P-Glycoprotein Are Sufficient to Mediate Drug Binding and Trafficking to the Cell Surface. J. Biol. Chem. 274, 24759\u201324765. 10.1074/jbc.274.35.24759", "ArticleIdList": ["10.1074/jbc.274.35.24759", "10455147"]}, {"Citation": "Ma Z., Hano Y., Nomura T., Chen Y. (2004). Novel Quinazoline-Quinoline Alkaloids with Cytotoxic and DNA Topoisomerase II Inhibitory Activities. Bioorg. Med. Chem. Lett. 14, 1193\u20131196. 10.1016/j.bmcl.2003.12.048", "ArticleIdList": ["10.1016/j.bmcl.2003.12.048", "14980663"]}, {"Citation": "Mahringer A., Karamustafa S., Klotz D., Kahl S., Konkimalla V. B., Wang Y., et al. (2010). Inhibition of P-Glycoprotein at the Blood-Brain Barrier by Phytochemicals Derived from Traditional Chinese Medicine. Cancer Genomics Proteomics 7, 191\u2013205.", "ArticleIdList": ["20656985"]}, {"Citation": "Mahringer A., Ott M., Reimold I., Reichel V., Fricker G. (2011). The ABC of the Blood-Brain Barrier - Regulation of Drug Efflux Pumps. Cpd 17, 2762\u20132770. 10.2174/138161211797440221", "ArticleIdList": ["10.2174/138161211797440221", "21827407"]}, {"Citation": "Makhey D., Gatto B., Yu C., Liu A., Liu L. F., LaVoie E. J. (1996). Coralyne and Related Compounds as Mammalian Topoisomerase I and Topoisomerase II Poisons. Bioorg. Med. Chem. 4, 781\u2013791. 10.1016/0968-0896(96)00054-5", "ArticleIdList": ["10.1016/0968-0896(96)00054-5", "8818227"]}, {"Citation": "Newman D. J., Cragg G. M., Snader K. M. (2003). Natural Products as Sources of New Drugs over the Period 1981\u22122002. J. Nat. Prod. 66, 1022\u20131037. 10.1021/np030096l", "ArticleIdList": ["10.1021/np030096l", "12880330"]}, {"Citation": "Ouchi H., Ishiguro H., Ikeda N., Hori M., Kubota Y., Uemura H. (2005). Genistein Induces Cell Growth Inhibition in Prostate Cancer through the Suppression of Telomerase Activity. Int. J. Urol. 12, 73\u201380. 10.1111/j.1442-2042.2004.00973.x", "ArticleIdList": ["10.1111/j.1442-2042.2004.00973.x", "15661057"]}, {"Citation": "Patwardhan B., Mashelkar R. A. (2009). Traditional Medicine-Inspired Approaches to Drug Discovery: Can Ayurveda Show the Way Forward? Drug Discov. Today 14, 804\u2013811. 10.1016/j.drudis.2009.05.009", "ArticleIdList": ["10.1016/j.drudis.2009.05.009", "19477288"]}, {"Citation": "Patwardhan B., Warude D., Pushpangadan P., Bhatt N. (2005). Ayurveda and Traditional Chinese Medicine: a Comparative Overview. Evidence-Based Complement. Altern. Med. 2, 465\u2013473. 10.1093/ecam/neh140", "ArticleIdList": ["10.1093/ecam/neh140", "PMC1297513", "16322803"]}, {"Citation": "Pauli-Magnus C., Rekersbrink S., Klotz U., Fromm M. F. (2001). Interaction of Omeprazole, Lansoprazole and Pantoprazole with P-Glycoprotein. Naunyn-Schmied Arch. Pharmacol. 364, 551\u2013557. 10.1007/s00210-001-0489-7", "ArticleIdList": ["10.1007/s00210-001-0489-7", "11770010"]}, {"Citation": "Pawagi A. B., Wang J., Silverman M., Reithmeier R. A. F., Deber C. M. (1994). Transmembrane Aromatic Amino Acid Distribution in P-Glycoprotein. J. Mol. Biol. 235, 554\u2013564. 10.1006/jmbi.1994.1013", "ArticleIdList": ["10.1006/jmbi.1994.1013", "7904655"]}, {"Citation": "Persil \u00d6., Hud N. V. (2007). Harnessing DNA Intercalation. Trends Biotechnology 25, 433\u2013436. 10.1016/j.tibtech.2007.08.003", "ArticleIdList": ["10.1016/j.tibtech.2007.08.003", "17825446"]}, {"Citation": "Pieters L., Vlietinck A. J. (2005). Bioguided Isolation of Pharmacologically Active Plant Components, Still a Valuable Strategy for the Finding of New Lead Compounds? J. Ethnopharmacology 100, 57\u201360. 10.1016/j.jep.2005.05.029", "ArticleIdList": ["10.1016/j.jep.2005.05.029", "15996842"]}, {"Citation": "Pratt S. J., Hern\u00e1ndez-Ochoa E., Martin S. S. (2020). Calcium Signaling: Breast Cancer's Approach to Manipulation of Cellular Circuitry. Biophys. Rev. 12, 1343\u20131359. 10.1007/s12551-020-00771-9", "ArticleIdList": ["10.1007/s12551-020-00771-9", "PMC7755621", "33569087"]}, {"Citation": "Rao U. S., Nuti S. L. (2003). Identification of Two Different States of P-Glycoprotein in its Catalytic Cycle. J. Biol. Chem. 278, 46576\u201346582. 10.1074/jbc.m308078200", "ArticleIdList": ["10.1074/jbc.m308078200", "12968025"]}, {"Citation": "Raviv Y., Pollard H. B., Bruggemann E. P., Pastan I., Gottesman M. M. (1990). Photosensitized Labeling of a Functional Multidrug Transporter in Living Drug-Resistant Tumor Cells. J. Biol. Chem. 265, 3975\u20133980. 10.1016/s0021-9258(19)39690-5", "ArticleIdList": ["10.1016/s0021-9258(19)39690-5", "1968065"]}, {"Citation": "Regev R., Yeheskely-Hayon D., Katzir H., Eytan G. D. (2005). Transport of Anthracyclines and Mitoxantrone across Membranes by a Flip-Flop Mechanism. Biochem. Pharmacol. 70, 161\u2013169. 10.1016/j.bcp.2005.03.032", "ArticleIdList": ["10.1016/j.bcp.2005.03.032", "15919056"]}, {"Citation": "Robert J., Jarry C. (2003). Multidrug Resistance Reversal Agents. J. Med. Chem. 46, 4805\u20134817. 10.1021/jm030183a", "ArticleIdList": ["10.1021/jm030183a", "14584929"]}, {"Citation": "Roberts M. F., Wink M. (1998). Alkaloids: Biochemistry, Ecology, and Medicinal Applications. New York: Plenum Press."}, {"Citation": "Rosenberg M. F., Callaghan R., Ford R. C., Higgins C. F. (1997). Structure of the Multidrug Resistance P-Glycoprotein to 2.5 Nm Resolution Determined by Electron Microscopy and Image Analysis. J. Biol. Chem. 272, 10685\u201310694. 10.1074/jbc.272.16.10685", "ArticleIdList": ["10.1074/jbc.272.16.10685", "9099718"]}, {"Citation": "Rosenberg M. F., Velarde G., Ford R. C., Martin C., Berridge G., Kerr I. D., et al. (2001). Repacking of the Transmembrane Domains of P-Glycoprotein during the Transport ATPase Cycle. EMBO J. 20, 5615\u20135625. 10.1093/emboj/20.20.5615", "ArticleIdList": ["10.1093/emboj/20.20.5615", "PMC125677", "11598005"]}, {"Citation": "Rosenberg M. F., Kamis A. B., Callaghan R., Higgins C. F., Ford R. C. (2003). Three-dimensional Structures of the Mammalian Multidrug Resistance P-Glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding. J. Biol. Chem. 278, 8294\u20138299. 10.1074/jbc.m211758200", "ArticleIdList": ["10.1074/jbc.m211758200", "12501241"]}, {"Citation": "Rosenkranz V., Wink M. (2008). Alkaloids Induce Programmed Cell Death in Bloodstream Forms of Trypanosomes (Trypanosoma B. Brucei). Molecules 13, 2462\u20132473. 10.3390/molecules13102462", "ArticleIdList": ["10.3390/molecules13102462", "PMC6244846", "18833031"]}, {"Citation": "Sayers T. J. (2011). Targeting the Extrinsic Apoptosis Signaling Pathway for Cancer Therapy. Cancer Immunol. Immunother. 60, 1173\u20131180. 10.1007/s00262-011-1008-4", "ArticleIdList": ["10.1007/s00262-011-1008-4", "21626033"]}, {"Citation": "Schmeller T., Latz-Br\u00fcning B., Wink M. (1997). Biochemical Activities of Berberine, Palmatine and Sanguinarine Mediating Chemical Defence against Microorganisms and Herbivores. Phytochemistry 44, 257\u2013266. 10.1016/s0031-9422(96)00545-6", "ArticleIdList": ["10.1016/s0031-9422(96)00545-6", "9004542"]}, {"Citation": "Seca A. M. L., Pinto D. (2018). Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. Int. J. Mol. Sci. 19, 263. 10.3390/ijms19010263", "ArticleIdList": ["10.3390/ijms19010263", "PMC5796209", "29337925"]}, {"Citation": "Seelig A. (1998). A General Pattern for Substrate Recognition by P-Glycoprotein. Eur. J. Biochem. 251, 252\u2013261. 10.1046/j.1432-1327.1998.2510252.x", "ArticleIdList": ["10.1046/j.1432-1327.1998.2510252.x", "9492291"]}, {"Citation": "Sharom F. J. (2011). The P-Glycoprotein Multidrug Transporter. Essays Biochem. 50, 161\u2013178. 10.1042/bse0500161", "ArticleIdList": ["10.1042/bse0500161", "21967057"]}, {"Citation": "Sharom F. J. (2014). Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function. Front. Oncol. 4, 41. 10.3389/fonc.2014.00041", "ArticleIdList": ["10.3389/fonc.2014.00041", "PMC3939933", "24624364"]}, {"Citation": "Shay J. W., Wright W. E. (2005). Senescence and Immortalization: Role of Telomeres and Telomerase. Carcinogenesis 26, 867\u2013874. 10.1093/carcin/bgh296", "ArticleIdList": ["10.1093/carcin/bgh296", "15471900"]}, {"Citation": "Sikic B. I. (1999). New Approaches in Cancer Treatment. Ann. Oncol. 10, 149\u2013153. 10.1023/a:1008355801988", "ArticleIdList": ["10.1023/a:1008355801988", "10676567"]}, {"Citation": "Stermitz F. R., Lorenz P., Tawara J. N., Zenewicz L. A., Lewis K. (2000). Synergy in a Medicinal Plant: Antimicrobial Action of Berberine Potentiated by 5'-methoxyhydnocarpin, a Multidrug Pump Inhibitor. Proc. Natl. Acad. Sci. 97, 1433\u20131437. 10.1073/pnas.030540597", "ArticleIdList": ["10.1073/pnas.030540597", "PMC26451", "10677479"]}, {"Citation": "Tait S. W. G., Green D. R. (2010). Mitochondria and Cell Death: Outer Membrane Permeabilization and beyond. Nat. Rev. Mol. Cell Biol 11, 621\u2013632. 10.1038/nrm2952", "ArticleIdList": ["10.1038/nrm2952", "20683470"]}, {"Citation": "Takara K., Sakaeda T., Okumura K. (2006). An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy. Cpd 12, 273\u2013286. 10.2174/138161206775201965", "ArticleIdList": ["10.2174/138161206775201965", "16454744"]}, {"Citation": "Ueda K., Taguchi Y., Morishima M. (1997). How Does P-Glycoprotein Recognize its Substrates? Semin. Cancer Biol. 8, 151\u2013159. 10.1006/scbi.1997.0066", "ArticleIdList": ["10.1006/scbi.1997.0066", "9441945"]}, {"Citation": "Ulrich-Merzenich G., Panek D., Zeitler H., Wagner H., Vetter H. (2009). New Perspectives for Synergy Research with the \"Omic\"-Technologies. Phytomedicine 16, 495\u2013508. 10.1016/j.phymed.2009.04.001", "ArticleIdList": ["10.1016/j.phymed.2009.04.001", "19428231"]}, {"Citation": "Ulrich-Merzenich G., Panek D., Zeitler H., Vetter H., Wagner H. (2010). Drug Development from Natural Products: Exploiting Synergistic Effects. Indian J. Exp. Biol. 48, 208\u2013219.", "ArticleIdList": ["21046973"]}, {"Citation": "Vernon J. A., Golec J. H., Dimasi J. A. (2010). Drug Development Costs when Financial Risk Is Measured Using the Fama-French Three-Factor Model. Health Econ. 19, 1002\u20131005. 10.1002/hec.1538", "ArticleIdList": ["10.1002/hec.1538", "19655335"]}, {"Citation": "Wagner H. (2011). Synergy Research: Approaching a New Generation of Phytopharmaceuticals. Fitoterapia 82, 34\u201337. 10.1016/j.fitote.2010.11.016", "ArticleIdList": ["10.1016/j.fitote.2010.11.016", "21075177"]}, {"Citation": "Walczak H., Krammer P. H. (2000). The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems. Exp. Cell Res. 256, 58\u201366. 10.1006/excr.2000.4840", "ArticleIdList": ["10.1006/excr.2000.4840", "10739652"]}, {"Citation": "Wang Y., Fang M. Y. (2006). Effect of Ginseng Saponin, Arsenic Trioxide, Beta-Elemene Combined with CTX on Telomere-Telomerase System in K562 Cell Line. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14, 1089\u20131095.", "ArticleIdList": ["17204170"]}, {"Citation": "Wang F., Lu C.-H., Willner I. (2014). From Cascaded Catalytic Nucleic Acids to Enzyme-DNA Nanostructures: Controlling Reactivity, Sensing, Logic Operations, and Assembly of Complex Structures. Chem. Rev. 114, 2881\u20132941. 10.1021/cr400354z", "ArticleIdList": ["10.1021/cr400354z", "24576227"]}, {"Citation": "Watkins R. E., Wisely G. B., Moore L. B., Collins J. L., Lambert M. H., Williams S. P., et al. (2001). The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity. Science 292, 2329\u20132333. 10.1126/science.1060762", "ArticleIdList": ["10.1126/science.1060762", "11408620"]}, {"Citation": "Wink M., Schimmer O. (2010). \u201cMolecular Modes of Action of Defensive Secondary Metabolites,\u201d in Annual Plant Reviews Volume 39: Functions and Biotechnology of Plant Secondary Metabolites (Wiley-Blackwell; ), 21\u2013161. 10.1002/9781444318876.ch2", "ArticleIdList": ["10.1002/9781444318876.ch2"]}, {"Citation": "Wink M., Van Wyk B.-E. (2008). Mind-altering and Poisonous Plants of the World. Portland, OR: Timber Press."}, {"Citation": "Wink M., Ashour M. L., El-Readi M. Z. (2012). Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents. Front. Microbiol. 3, 130. 10.3389/fmicb.2012.00130", "ArticleIdList": ["10.3389/fmicb.2012.00130", "PMC3332394", "22536197"]}, {"Citation": "Wink M. (1999). Biochemistry of Plant Secondary Metabolism. Sheffield, England, Boca Raton, FL: Sheffield Academic Press; CRC Press."}, {"Citation": "Wink M. (2000). \u201cInterference of Alkaloids with Neuroreceptors and Ion Channels,\u201d in Studies in Natural Products Chemistry. Editor Atta ur R. (Amsterdam: Elsevier; ), 3\u2013122. 10.1016/s1572-5995(00)80004-6", "ArticleIdList": ["10.1016/s1572-5995(00)80004-6"]}, {"Citation": "Wink M. (2003). Evolution of Secondary Metabolites from an Ecological and Molecular Phylogenetic Perspective. Phytochemistry 64, 3\u201319. 10.1016/s0031-9422(03)00300-5", "ArticleIdList": ["10.1016/s0031-9422(03)00300-5", "12946402"]}, {"Citation": "Wink M. (2007). \u201cChapter 1 Molecular Modes of Action of Cytotoxic Alkaloids: From DNA Intercalation, Spindle Poisoning, Topoisomerase Inhibition to Apoptosis and Multiple Drug Resistance,\u201d in The Alkaloids: Chemistry and Biology. Editor Cordell G. A., 1\u201347. 10.1016/s1099-4831(07)64001-2", "ArticleIdList": ["10.1016/s1099-4831(07)64001-2", "18085328"]}, {"Citation": "Wink M. (2008). Evolutionary Advantage and Molecular Modes of Action of Multi-Component Mixtures Used in Phytomedicine. Cdm 9, 996\u20131009. 10.2174/138920008786927794", "ArticleIdList": ["10.2174/138920008786927794", "19075616"]}, {"Citation": "Wink M. (2010). Introduction: Biochemistry, Physiology and Ecological Functions of Secondary Metabolites. Hoboken, NJ: Wiley-Blackwell."}, {"Citation": "Wink M. (2015). Modes of Action of Herbal Medicines and Plant Secondary Metabolites. Medicines 2, 251\u2013286. 10.3390/medicines2030251", "ArticleIdList": ["10.3390/medicines2030251", "PMC5456217", "28930211"]}, {"Citation": "Xing L., Hu Y., Lai Y. (2009). Advancement of Structure-Activity Relationship of Multidrug Resistance-Associated Protein 2 Interactions. AAPS J. 11, 406\u2013413. 10.1208/s12248-009-9117-0", "ArticleIdList": ["10.1208/s12248-009-9117-0", "PMC2758110", "19495992"]}, {"Citation": "Yokoyama M., Noguchi M., Nakao Y., Ysunaga M., Yamasaki F., Iwasaka T. (2008). Antiproliferative Effects of the Major Tea Polyphenol, (\u2212)-epigallocatechin Gallate and Retinoic Acid in Cervical Adenocarcinoma. Gynecol. Oncol. 108, 326\u2013331. 10.1016/j.ygyno.2007.10.013", "ArticleIdList": ["10.1016/j.ygyno.2007.10.013", "18035403"]}, {"Citation": "Zhang J., Tu Y., Smith-Schneider S. (2005). Activation of P53, Inhibition of Telomerase Activity and Induction of Estrogen Receptor Beta Are Associated with the Anti-growth Effects of Combination of Ovarian Hormones and Retinoids in Immortalized Human Mammary Epithelial Cells. Cancer Cell Int 5, 6. 10.1186/1475-2867-5-6", "ArticleIdList": ["10.1186/1475-2867-5-6", "PMC555559", "15755327"]}, {"Citation": "Zhou J., Giannakakou P. (2005). Targeting Microtubules for Cancer Chemotherapy. Cmcaca 5, 65\u201371. 10.2174/1568011053352569", "ArticleIdList": ["10.2174/1568011053352569", "15720262"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "25"}, {"Year": "2021", "Month": "4", "Day": "12"}, {"Year": "2021", "Month": "6", "Day": "7", "Hour": "5", "Minute": "49"}, {"Year": "2021", "Month": "6", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "8", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "5", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["34093189", "PMC8176113", "10.3389/fphar.2021.658513", "658513"]}}], "PubmedBookArticle": []}